EX-10.1(1) 5 ea021197601ex10-1i_silexion.htm FINAL INVOICE ISSUED BY EARLYBIRDCAPITAL, INC. TO MORINGA ACQUISITION CORP UNDER THE BUSINESS COMBINATION MARKETING AGREEMENT, DATED FEBRUARY 16, 2021, BY AND BETWEEN EARLYBIRDCAPITAL, INC. AND MORINGA ACQUISITION CORP

Exhibit 10.1.1

 

EarlyBirdCapital, Inc.

366 Madison Avenue – 8th Floor

New York, NY 10017

 

 

Member FINRA SIPC

 

Telephone: (212) 661-0200 Facsimile: (212) 661-4936

 

 

 

INVOICE

 

 

 

DATE:8/11/2024

 

TO:Moringa Acquisition Corp
250 Park Avenue, 7th Floor
New York, NY, 10017

 

 Attention: Ilan Levin
Chairman and Chief Executive Officer

 

 

 

For services rendered in connection with Moringa’s business combination with Silexion Therapeutics Ltd., please remit the amount set forth below:

 

Cash portion of BCMA payable at closing  $350,000 
BCMA payable in Convertible Promissory Note   1,250,000 
Total  $1,600,000 

 

 

 

PAYMENT INSTRUCTIONS

 

Please send payment via wire transfer to:

 

Citibank N.A.

ABA Routing Number: [__________]

For the account of: EarlyBirdCapital, Inc.

Account Number: [_________]